|
⚲
|
| Keyboard |
| Cunningham Emmett
✚
|
|
|---|---|
| CIK # | 0001710382 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001710382] | |
| 4 | [0001710382] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NovaBridge Biosciences | |
| Cunningham Emmett | |
| Galera Therapeutics Inc | |
| Annexon Inc | |
| Lumos Pharma Inc | |
| Venus Concept Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2023-06-14 | Grant | 48,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2022-06-15 | Grant | 15,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2021-07-01 | Grant | 5,408 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2021-06-16 | Grant | 9,888 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2020-06-09 | Grant | 9,888 | $0.00 | |
|
Lumos Pharma Inc (LUMO)
Stock Option (Right to Buy) · derivative
|
2020-04-03 | Grant | 5,684 | $0.00 | |
|
Lumos Pharma Inc (LUMO)
Common Stock
|
2020-04-03 | Grant | 709 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Options (Right to Buy) · derivative
|
2019-11-06 | Grant | 19,776 | $0.00 |